14 febrero 2015
In the first experimental use of algorithms that employ structure-based molecular modeling to optimize deimmunized drug candidates, researchers complement their prior sequence-based deimmunizing algorithms and expand the tool kit of protein engineering technologies to use in next generation drug development.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/tcANvrCFJMI/150214092454.htm
